Instructions and FAQs

iReadMore is a therapy for individuals with acquired reading impairments (known as pure alexia, central alexia or aphasia).

Reading impairments can be acquired after a stroke, brain injury, brain tumour or certain neurodegenerative disorders (such as primary progressive aphasia).

iReadMore is NOT designed to treat reading disorders that started in childhood (such as developmental dyslexia) or visual reading disorders (such as hemianopia or visual neglect).

Download iReadMore on Google Play by clicking here.

iReadMore uses repetition training to rebuild associations between spoken words, pictures and written words to improve reading speed and accuracy.

The training adapts to the user's performance which makes it suitable for different types and severities of reading impairments.

Improvement in reading abilities will be specific to words that are trained in the app and not untrained words.

A number of research papers on iReadMore have been published in peer-reviewed academic journals. Research on iReadMore is continuing to further develop the therapy and improve our understanding of reading rehabilitation.

The comprehensive list of Neurotherapeutics Group publications can be found here.

We cannot say exactly how much you will improve as results will vary.

In a clinical trial, people with central alexia who used iReadMore for 35 hours over 4 weeks improved their word reading accuracy by 8.7% on average, and their reading speed got faster by 100ms.

iReadMore was developed by a team of researchers at UCL in collaboration with software development company, Quiley Ltd.

People with aphasia have been acitvely involved in all stages of the research and development, including designing the app to ensure it is accessible and engaging.

This work was funded by the Medical Research Council (grant codes: MR/K022563/1 and MR/R015759/1) and UKRI (KEI2019-06-01).

iReadMore is registered with the Medicines and Healthcare products Regulatory Agency (MHRA) as a Class I Medical Device. 

iReadMore may be beneficial for treating changes to reading caused by the acquired impairment. However, it is not designed to treat reading disorders that started in childhood.

To watch an aphasia-friendly video guide to setting up a Google Play account, please click here.

We recommend using iReadMore every day for a duration that you find comfortable. If you start to get tired or fatigued, please take a break and continue tomorrow.

You do not have to read the words aloud for the therapy to work. However, you may find reading aloud helps.

All users get a free 7 day trial period with full access to the tests and therapy. After the free trial, iReadMore costs £5 per month.

As a non-profit organisation, all funding gets reinvested into the research, maintenance and development of the iReadMore therapy app.

When your free trial or previous subscription ends. You will be able to pay for your next subscription period in the app. Please click on 'Help' for more information on your subscription and to watch the subscription video for more details.

The subscription ends autmotically and does not auto-renew at the end of the subscription period. 

If you do not think iReadMore is working, please email us at ireadmore@ucl.ac.uk and we will try to resolve the problem for you.

iReadMore can be used on an Android mobile phone or tablet. Examples of manufactures making android devices are Samsung, Google, LG, Lenovo, Nokia and Huawei.

We are still developing the Apple iPad and iPhone version of the app. We expect this to be released soon! 

At present, you can only access iReadMore from an Android tablet or mobile phone. We are still developing the Apple iPad and iPhone version of the app and expect this to be released soon!